DK0767666T3 - Fremgangsmåder og præparater, der er anvendelige ved profylakse og behandling af endotoksin-relaterede tilstande - Google Patents

Fremgangsmåder og præparater, der er anvendelige ved profylakse og behandling af endotoksin-relaterede tilstande

Info

Publication number
DK0767666T3
DK0767666T3 DK95930812T DK95930812T DK0767666T3 DK 0767666 T3 DK0767666 T3 DK 0767666T3 DK 95930812 T DK95930812 T DK 95930812T DK 95930812 T DK95930812 T DK 95930812T DK 0767666 T3 DK0767666 T3 DK 0767666T3
Authority
DK
Denmark
Prior art keywords
endotoxin
prophylaxis
treatment
methods
related conditions
Prior art date
Application number
DK95930812T
Other languages
Danish (da)
English (en)
Inventor
Daniel M Levine
Thomas S Parker
Albert L Rubin
Bruce R Gordon
Stuart D Saal
Original Assignee
Sepsicure L L C
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26965092&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK0767666(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from US08/288,568 external-priority patent/US5506218A/en
Application filed by Sepsicure L L C filed Critical Sepsicure L L C
Application granted granted Critical
Publication of DK0767666T3 publication Critical patent/DK0767666T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
    • A61K31/685—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A61K9/1275—Lipoproteins or protein-free species thereof, e.g. chylomicrons; Artificial high-density lipoproteins [HDL], low-density lipoproteins [LDL] or very-low-density lipoproteins [VLDL]; Precursors thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/775—Apolipopeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Toxicology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Dispersion Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DK95930812T 1994-08-10 1995-08-10 Fremgangsmåder og præparater, der er anvendelige ved profylakse og behandling af endotoksin-relaterede tilstande DK0767666T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/288,568 US5506218A (en) 1992-08-12 1994-08-10 Methods useful in endotoxin based therapy
US08/487,459 US5674855A (en) 1992-08-12 1995-06-07 Methods and compositions useful in prophylaxis and therapy of endotoxin related conditions
PCT/US1995/010189 WO1996004916A1 (fr) 1994-08-10 1995-08-10 Procede et compositions utiles dans la prophylaxie et la therapie d'etats lies a l'endotoxine

Publications (1)

Publication Number Publication Date
DK0767666T3 true DK0767666T3 (da) 2004-04-05

Family

ID=26965092

Family Applications (1)

Application Number Title Priority Date Filing Date
DK95930812T DK0767666T3 (da) 1994-08-10 1995-08-10 Fremgangsmåder og præparater, der er anvendelige ved profylakse og behandling af endotoksin-relaterede tilstande

Country Status (26)

Country Link
US (1) US5674855A (fr)
EP (1) EP0767666B1 (fr)
JP (1) JP3818660B2 (fr)
CN (1) CN1137688C (fr)
AP (1) AP782A (fr)
AT (1) ATE255415T1 (fr)
AU (1) AU703861C (fr)
BG (1) BG61967B1 (fr)
BR (1) BR9508584A (fr)
CA (1) CA2196906C (fr)
CY (1) CY2514B1 (fr)
CZ (1) CZ287614B6 (fr)
DE (1) DE69532239T2 (fr)
DK (1) DK0767666T3 (fr)
ES (1) ES2211915T3 (fr)
FI (1) FI118035B (fr)
HU (1) HUT77605A (fr)
NO (1) NO313786B1 (fr)
NZ (1) NZ292315A (fr)
OA (2) OA11737A (fr)
PL (1) PL182043B1 (fr)
PT (1) PT767666E (fr)
RO (1) RO115782B1 (fr)
RU (1) RU2174839C2 (fr)
SK (1) SK282493B6 (fr)
WO (1) WO1996004916A1 (fr)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6518412B1 (en) 1997-09-29 2003-02-11 Jean-Louis Dasseux Gene therapy approaches to supply apolipoprotein A-I agonists and their use to treat dyslipidemic disorders
US6046166A (en) 1997-09-29 2000-04-04 Jean-Louis Dasseux Apolipoprotein A-I agonists and their use to treat dyslipidemic disorders
US6004925A (en) 1997-09-29 1999-12-21 J. L. Dasseux Apolipoprotein A-I agonists and their use to treat dyslipidemic disorders
US6037323A (en) * 1997-09-29 2000-03-14 Jean-Louis Dasseux Apolipoprotein A-I agonists and their use to treat dyslipidemic disorders
AU3809900A (en) * 1999-03-09 2000-09-28 Max-Delbruck-Centrum Fur Molekulare Medizin Therapy and use of compounds in therapy
US20030032674A1 (en) * 2001-08-13 2003-02-13 Hwang Daniel H. Use of unsaturated fatty acids to treat severe inflammatory diseases
US20040067873A1 (en) 2002-05-17 2004-04-08 Dasseux Jean-Louis H. Method of treating dyslipidemic disorders
EP1589834B1 (fr) * 2003-02-05 2007-04-11 N.V. Nutricia Composition enterale pour la prevention et/ou le traitement d'une septicemie
ES2372499T3 (es) 2004-05-19 2012-01-20 Los Angeles Biomedical Research Institute At Harbor-Ucla Medical Center Uso de un detergente para la eliminación no quirúrgica de grasa.
US7754230B2 (en) * 2004-05-19 2010-07-13 The Regents Of The University Of California Methods and related compositions for reduction of fat
US20060127468A1 (en) 2004-05-19 2006-06-15 Kolodney Michael S Methods and related compositions for reduction of fat and skin tightening
BRPI0615411A2 (pt) * 2005-08-29 2012-12-04 Sepsicure L L C uso de um ácido da bìlis ou de um sal de ácido da bìlis e um fosfolipìdeo
GB0522942D0 (en) 2005-11-10 2005-12-21 Leigh Steven Dissolution composition
US8163699B2 (en) 2006-06-01 2012-04-24 Montreal Heart Institute Method for the treatment of valvular disease
KR100785656B1 (ko) * 2007-05-14 2007-12-17 재단법인서울대학교산학협력재단 소염제로 사용되는 소디움글리코콜레이트 또는 그 유도체
RU2351351C1 (ru) * 2007-08-08 2009-04-10 Тихоокеанский Институт Биоорганической Химии Дальневосточного Отделения Российской Академии Наук (Тибох Дво Ран) Средство, повышающее неспецифическую сопротивляемость организма к бактериальным эндотоксинам
AU2010213568B2 (en) 2009-02-16 2014-11-20 Cerenis Therapeutics Holding Sa Apolipoprotein A-I Mimics
US8101593B2 (en) 2009-03-03 2012-01-24 Kythera Biopharmaceuticals, Inc. Formulations of deoxycholic acid and salts thereof
CA2827643C (fr) 2011-02-18 2019-05-07 Kythera Biopharmaceuticals, Inc. Traitement de graisse sous-mentale
US8653058B2 (en) 2011-04-05 2014-02-18 Kythera Biopharmaceuticals, Inc. Compositions comprising deoxycholic acid and salts thereof suitable for use in treating fat deposits
US9023833B2 (en) * 2012-12-18 2015-05-05 Sepsicure, LLC Method for treating sepsis in patients with albumin, cholesterol and HDL levels above minimum thresholds

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4115313A (en) * 1974-10-08 1978-09-19 Irving Lyon Bile acid emulsions
DE2556592C2 (de) * 1975-12-16 1986-10-09 A. Nattermann & Cie GmbH, 5000 Köln Arzneimittelzubereitungen auf Basis öliger Lösungen von Phospholipiden
US4314997A (en) * 1980-10-06 1982-02-09 Edward Shanbrom Purification of plasma protein products
IL63734A (en) * 1981-09-04 1985-07-31 Yeda Res & Dev Lipid fraction,its preparation and pharmaceutical compositions containing same
CA1237671A (fr) * 1983-08-01 1988-06-07 Michael W. Fountain Augmentation de l'activite pharmaceutique
JPS6193111A (ja) * 1984-05-28 1986-05-12 Funayama Seizo 発熱性物質除去方法
US5032585A (en) * 1987-02-17 1991-07-16 Board Of Regents, The University Of Texas System Methods and compositions employing unique mixtures of polar and neutral lipids for surfactant replacement therapy
AU614465B2 (en) * 1989-04-05 1991-08-29 Yissum Research Development Company Of The Hebrew University Of Jerusalem Medicinal emulsions
DE4017979A1 (de) * 1990-06-05 1991-12-12 Meyer Lucas Gmbh & Co Lipid- bzw. phospholipid-zusammensetzungen sowie diese enthaltendes mittel zur behandlung von erkrankungen sowie auf die zellmembrane zurueckzufuehrende stoerungen
BR9201168A (pt) * 1992-04-02 1994-04-12 Zerbini E J Fundacao Microemulsoes usadas como velculo para carregar quimioterapicos as celulas neoplasicas

Also Published As

Publication number Publication date
CZ287614B6 (en) 2001-01-17
CZ37197A3 (en) 1997-10-15
HUT77605A (hu) 1998-06-29
OA11737A (en) 2005-05-12
CN1137688C (zh) 2004-02-11
EP0767666B1 (fr) 2003-12-03
AU3405295A (en) 1996-03-07
CA2196906C (fr) 2004-03-02
PT767666E (pt) 2004-04-30
DE69532239T2 (de) 2004-10-21
AU703861B2 (en) 1999-04-01
BG61967B1 (bg) 1998-11-30
NO970582D0 (no) 1997-02-07
WO1996004916A1 (fr) 1996-02-22
RO115782B1 (ro) 2000-06-30
NZ292315A (en) 1998-10-28
FI118035B (fi) 2007-06-15
PL182043B1 (pl) 2001-10-31
OA10598A (en) 2002-07-15
HK1003709A1 (en) 1998-11-06
ES2211915T3 (es) 2004-07-16
CA2196906A1 (fr) 1996-02-22
AP9700921A0 (en) 1997-01-31
CY2514B1 (en) 2005-12-23
JP3818660B2 (ja) 2006-09-06
RU2174839C2 (ru) 2001-10-20
AP782A (en) 1999-11-15
JPH10504037A (ja) 1998-04-14
EP0767666A4 (fr) 1998-10-07
DE69532239D1 (de) 2004-01-15
CN1158087A (zh) 1997-08-27
NO970582L (no) 1997-04-07
NO313786B1 (no) 2002-12-02
BR9508584A (pt) 1997-10-21
BG101288A (en) 1997-09-30
AU703861C (en) 2001-12-20
SK282493B6 (sk) 2002-02-05
EP0767666A1 (fr) 1997-04-16
PL318593A1 (en) 1997-06-23
SK17697A3 (en) 1997-09-10
FI970534L (fi) 1997-02-07
FI970534A0 (fi) 1997-02-07
US5674855A (en) 1997-10-07
ATE255415T1 (de) 2003-12-15

Similar Documents

Publication Publication Date Title
FI970859A7 (fi) Metallien käsittelykoostumus ja -prosessi
NO942024L (no) Konsoliderbart partikkelformet materiale og fremgangsmåte ved brönnbehandling
NO940825D0 (no) 2-Debenzoyl-2-acyltaxolderivater og fremgangsmåter ved fremstilling derav
NO970373D0 (no) Benzoksazoler og pyridinderivater anvendelige ved behandling av type-II-diabetes
NO983965D0 (no) Polymer-organoleire-kompositter og deres fremstilling
FI950587L (fi) Endotoksiinimyrkytyksen ennaltaehkäisyssä ja hoidossa käyttökelpoisia menetelmiä
NO995119L (no) Prosessering av NMR-logger ved bruk av "Wavelet"-filter og iterativ inversjon
NO972235D0 (no) Termisk metalesepolymerisasjonsfremgangsmåte og polymeriserbar sammensetning
NO972451D0 (no) 2-heterocyklyloksy og tiometyl-1,2,5-tiadiazolidin-3-on 1,1-dioksider og preparater og fremgangsmåte for anvendelse derav
NO970582D0 (no) Fremgangsmåte og blandinger nyttige i protylakse og behandling av endotoksin-relaterte tilstander
DK141494A (da) Forbedringer af og i relation til kødbehandling
DK91793A (da) Fremgangsmåde til overfladebehandling, midler til udøvelse og anvendelsen heraf
NO984836D0 (no) Substituerte benzylaminer og deres anvendelse for behandling av depresjon
FI951060L (fi) Formulaatioita ja hoitomenetelmiä
NO173823C (no) Fremgangsmaate for fremstilling av (s)- -ethyl-2-oxo-1-pyrrolidinacetamid og mellomprodukt for anvendelse ved fremgangsmaaten
DK4491D0 (da) Aclonifen-baserede herbicidblandinger og deres anvendelse
FI964227A7 (fi) Hepariinia sitova proteiini verenmyrkytyksen hoitoon ja menetelmät sen valmistamiseksi
NO302411B1 (no) Partikulært sprengstoff og fremgangsmåte ved dets fremstilling
NO984979D0 (no) Biologisk materiale som er fritt for virale og molekylµre patogener samt fremgangsmÕte ved fremstilling derav
NO890643D0 (no) Fremgangsmaate ved behandling av avluft og avgass.
DK0548520T3 (da) Fremgangsmåde til fremstilling af 2-alkoxymethylacrolein og dets anvendelse til fremstilling af 3-alkoxymethylquinoliner
NO972118D0 (no) Termostabile blandinger med bedret latens, fremgangsmåte for fremstilling og anvendelse derav
DK508586D0 (da) Anordning ved nedlaebsbraende og hertil anvendeligt filterorgan
NO971419L (no) Fremgangsmåte for fremstilling av 1,3-alkendioler og 3-hydroksyaldehyder
NO932315L (no) Overflateaktivt middel, fremgangsmåte ved dets fremstilling og anvendelse